# Glutamine PET Imaging Colorectal Cancer

> **NCT03275974** · PHASE1 · TERMINATED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 6 (actual)

## Conditions studied

- RAS Wild Type
- Stage IV Colorectal Cancer
- Stage IVA Colorectal Cancer
- Stage IVB Colorectal Cancer

## Interventions

- **BIOLOGICAL:** Carbon C 11 Glutamine
- **BIOLOGICAL:** Fluorine F 18 L-glutamate Derivative BAY94-9392
- **PROCEDURE:** Positron Emission Tomography
- **PROCEDURE:** Blood Draw

## Key facts

- **NCT ID:** NCT03275974
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-04-27
- **Primary completion:** 2025-12-23
- **Final completion:** 2025-12-23
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** \<75% participation
- **Last updated:** 2026-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03275974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03275974, "Glutamine PET Imaging Colorectal Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03275974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*